Compare Heron Therapeutics Inc (HRTX) vs ArcelorMittal SA (MT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs ArcelorMittal SA — how do they compare? Heron Therapeutics Inc trades at $0.32 (market cap $61.47M), while ArcelorMittal SA trades at $74.2 (market cap $55.88B). The key difference: ArcelorMittal SA is far larger — about 909.1× Heron Therapeutics Inc's market cap, and ArcelorMittal SA pays a 0.81% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | MT | |
|---|---|---|
Market Cap | $61.47M | $55.88B |
Sector | Health | Basic Materials |
52-Week High | $1.49 | $75.35 |
52-Week Low | $0.32 | $32.44 |
Enterprise Value | $168.21M | $65.45B |
Dividend Yield | — | 0.81% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About ArcelorMittal SA
ArcelorMittal SA is involved in the steel industry. The company's operating segments include NAFTA
Read more on MT →
